Anemia
"Gene Therapy for Long-Term Expression of Erythropoietin in Rats."
Published in Blood Weekly, September 25th, 1995
According to the authors' abstract of an article published in Proceedings of the National Academy of Sciences of the United States of America, "The injection of recombinant erythropoietin (Epo) is now widely used for long-term treatment of anemia associated with chronic renal failure, cancer, and human immunodeficiency virus infections. The ability to deliver this hormone by gene therapy rather than by repeated injections could provide substantial clinical and economic benefits. As a preliminary approach. We investigated in rats the expression and biological effects of transplanting autologous vascular smooth muscle cells transduced with a retroviral vector encoding rat Epo cDNA. ...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1995-09-25)
More Articles from Blood Weekly
- Conference Coverage/AATB
Association Approves Revised Tissue Banking Standards - Conference Coverage/AATB
No Final Proposed FDA Tissue Regulations Are in Sight - Blood Banking
FDA Approval of PLA To Test for HTLV-I Received - Blood Banking
Hospital Takes FDA Action Seriously, Vows To Correct Procedures - Commentary
When Good Can Be Better Than Best - Industry News/Clinical Trials
FDA Clearance Received To Begin Human Testing of Cancer Drug - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
